Skip to Content

Measles Virus Vaccine / Rubella Virus Vaccine Dosage

Usual Adult Dose for:

Usual Pediatric Dose for:

Additional dosage information:

Usual Adult Dose for Rubella Prophylaxis

0.5 mL subcutaneously preferably into the outer aspect of the upper arm.

Usual Adult Dose for Measles Prophylaxis

0.5 mL subcutaneously preferably into the outer aspect of the upper arm.

Usual Pediatric Dose for Rubella Prophylaxis

>= 12 months: 0.5 mL subcutaneously preferably into the outer aspect of the upper arm. The initial dose is generally given at 15 months of age and followed by a booster between the ages of 4 to 6 years.

MMR is indicated for use in patients >= 15 months. However, in relatively inaccessible populations for whom immunization programs are logistically difficult and in population groups in which natural measles infection may occur in a significant proportion of patients before 15 months of age, it may be desirable to administer measles vaccine at an earlier age.

<12 months: Single antigen measles vaccine should be administered with a dose of MMR administered at >= 12 months of age.

Usual Pediatric Dose for Measles Prophylaxis

>= 12 months: 0.5 mL subcutaneously preferably into the outer aspect of the upper arm. The initial dose is generally given at 15 months of age and followed by a booster between the ages of 4 to 6 years.

MMR is indicated for use in patients >= 15 months. However, in relatively inaccessible populations for whom immunization programs are logistically difficult and in population groups in which natural measles infection may occur in a significant proportion of patients before 15 months of age, it may be desirable to administer measles vaccine at an earlier age.

<12 months: Single antigen measles vaccine should be administered with a dose of MMR administered at >= 12 months of age.

Other Comments

Common adverse reactions and all serious reactions that occur during administration should be reported to the U.S. Department of Health and Human Services Vaccine Adverse Event Reporting System. Reporting forms and information regarding the completion of the form can be obtained at 1-800-822-7967.

The ACIP (Advisory Committee on Immunization Practices) recommends that live-virus vaccines not administered on the same day should be administered at least 30 days apart. There is concern that the vaccine given first could interfere with response to the vaccine given second. ACIP recommends that if two live parenteral vaccines are given less than 28 days apart, the vaccine given second should not be counted as valid and should be repeated at least 4 weeks later. One exception to this recommendation is that yellow fever vaccine may be given at any time after measles vaccine.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide